文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

灯盏花乙素通过调控CCN1表达抑制核因子-κB信号通路减轻脂多糖诱导的肾损伤

[Scutellarin alleviates lipopolysaccharide-induced renal injury via mediating cysteine-rich protein 61-connective tissue growth factor-nephroblastoma overexpressed gene 1 expression to inhibit nuclear factor-κB signaling pathway].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2022-01-01
一句话结论动物与细胞实验显示灯盏花乙素经CCN1抑制NF-κB通路减轻脂多糖诱导的急性肾损伤,属机制性实验证据。

该研究为动物实验与体外细胞实验,观察灯盏花乙素(Scu)对脓毒症相关急性肾损伤(SA-AKI)的保护作用及机制。体内实验将36只雄性C57BL/6小鼠分为生理盐水对照组、脂多糖(LPS)诱导SA-AKI模型组、20 mg/kg Scu对照组及5、10、20 mg/kg Scu预处理组,每组6只,LPS按10 mg/kg腹腔注射造模,Scu预处理组于LPS注射前每日腹腔注射不同剂量Scu持续1周;结果显示Scu可剂量依赖性减轻肾功能与组织学损伤,并降低肾组织NF-κB通路相关分子及CCN1蛋白表达、减轻细胞凋亡。体外实验在HK-2细胞中显示过表达CCN1可抑制LPS诱导的IL-1β、TNF-α、MCP-1 mRNA表达并下调凋亡相关蛋白,而siRNA抑制CCN1则相反;Scu处理可下调上述炎症因子mRNA及凋亡相关蛋白,抑制CCN1后Scu的保护作用减弱。结论认为Scu的保护作用与NF-κB信号通路及CCN1相关。

要点

  • 体内实验:36只雄性C57BL/6小鼠分6组每组6只,LPS 10 mg/kg腹腔注射造SA-AKI模型,Scu 5、10、20 mg/kg于LPS前每日腹腔注射1周。
  • Scu可剂量依赖性减轻SA-AKI小鼠肾功能下降与肾组织学损伤,并减少肾组织NF-κB通路相关分子及CCN1蛋白表达、减轻凋亡。
  • 体外LPS处理的HK-2细胞中,过表达CCN1显著抑制IL-1β mRNA(3.20±0.57 vs. 4.88±0.69)、TNF-α mRNA(2.99±0.44 vs. 5.00±0.81)、MCP-1 mRNA(2.81±0.50 vs. 5.41±0.75),均P<0.05,并下调凋亡相关蛋白。
  • siRNA抑制CCN1后,LPS刺激HK-2细胞IL-1β mRNA(6.01±1.13 vs. 4.88±0.69)、TNF-α mRNA(5.15±0.86 vs. 5.00±0.81)显著升高(均P<0.05),凋亡相关蛋白上调。
  • LPS诱导HK-2细胞经Scu处理后IL-1β mRNA(2.55±0.50 vs. 6.15±1.04)、TNF-α mRNA(2.58±0.40 vs. 3.95±0.52)、MCP-1 mRNA(2.64±0.44 vs. 6.21±0.96)显著下调(均P<0.05);

适用人群与场景

  • 体内实验:雄性C57BL/6小鼠,LPS 10 mg/kg腹腔注射诱导SA-AKI模型。
  • 体外实验:人肾小管上皮细胞系HK-2,细胞融合至80%后用于实验,以100 g/L LPS处理。

处置流程与药物剂量

  • 体内实验:Scu预处理组于LPS注射前每日腹腔注射5、10或20 mg/kg Scu,持续1周;LPS注射后24小时处死小鼠取肾组织。
  • 体外实验:HK-2细胞以100 g/L LPS处理,并加入20 μmol/L Scu;另转染pcDNA3.1-CCN1或CCN1 siRNA以过表达或抑制CCN1。

研究设计与关键结果

  • 体内实验:LPS诱导的SA-AKI小鼠肾功能显著下降,出现肾脏组织学损伤及肾小管严重损伤;Scu可剂量依赖性减轻肾功能与组织学损伤。
  • 体内实验:Western blotting显示Scu可降低肾组织NF-κB信号通路相关分子及CCN1蛋白表达,对细胞凋亡有明显减轻作用。
  • 体外实验:未用LPS处理的HK-2细胞中,过表达CCN1对凋亡相关蛋白及NF-κB通路促炎因子无影响。
  • 体外实验:LPS处理的HK-2细胞中,过表达CCN1显著抑制IL-1β mRNA(3.20±0.57 vs. 4.88±0.69)、TNF-α mRNA(2.99±0.44 vs. 5.00±0.81)、MCP-1 mRNA(2.81±0.50 vs. 5.41±0.75),均P<0.05,并显著下调凋亡相关蛋白。
  • 体外实验:siRNA抑制CCN1后,LPS刺激的HK-2细胞IL-1β mRNA(6.01±1.13 vs. 4.88±0.69)、TNF-α mRNA(5.15±0.86 vs. 5.00±0.81)显著升高,均P<0.05,凋亡相关蛋白显著上调。
  • 体外实验:LPS诱导的HK-2细胞经Scu处理后IL-1β mRNA(2.55±0.50 vs. 6.15±1.04)、TNF-α mRNA(2.58±0.40 vs. 3.95±0.52)、MCP-1 mRNA(2.64±0.44 vs. 6.21±0.96)显著下调,均P<0.05,凋亡相关蛋白亦显著减少。
  • 体外实验:siRNA抑制CCN1后Scu保护作用减弱,IL-1β mRNA(5.34±0.76 vs. 2.55±0.50)、TNF-α mRNA(3.66±0.54 vs. 2.58±0.40)、MCP-1 mRNA(5.15±0.79 vs. 2.64±0.44)显著上调,均P<0.05,凋亡相关蛋白亦显著上调。

证据类型、等级与局限

  • 证据类型:动物实验与体外细胞实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文结论认为Scu可保护SA-AKI小鼠肾功能,其保护作用与NF-κB信号通路及CCN1相关,Scu通过调控NF-κB信号通路减轻LPS诱导的肾损伤;原文未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the protective effect and mechanism of scutellarin (Scu) on sepsis associated-acute kidney injury (SA-AKI).

METHODS: (1) In vivo experiment: 36 male C57BL/6 mice were divided into normal saline (NS) control group, lipopolysaccharide (LPS) induced SA-AKI model group (LPS group), 20 mg/kg Scu control group (Scu 20 control group), and 5, 10, 20 mg/kg Scu pretreatment groups by random number table with 6 mice in each group. The SA-AKI model was reproduced by intraperitoneal injection of 10 mg/kg LPS. The NS control group was injected with NS intraperitoneally. The Scu pretreatment groups were intraperitoneally injected with different doses of Scu every day before LPS injection for 1 week. Scu 20 control group was injected with 20 mg/kg Scu for 1 week. After 24 hours of LPS treatment, mice in each group were sacrificed, kidney tissues were collected, and kidney injury was detected by hematoxylin-eosin (HE) staining. Western blotting was used to detect the protein expression levels of nuclear factor-κB (NF-κB) signaling pathway related molecules, apoptosis-related proteins and cysteine-rich protein 61-connective tissue growth factor-nephroblastoma overexpressed gene 1 (CCN1). (2) In vitro experiment: human renal tubular epithelial cell line HK-2 was cultured in vitro and used for experiment when the cells fused to 80%. In the cells without LPS treatment and after 100 g/L LPS treatment, pcDNA3.1-CCN1 and small interfering RNA (siRNA) CCN1 sequence were transfected to overexpress and inhibit CCN1 expression, respectively, to observe whether CCN1 was involved in NF-κB signaling pathway activation and apoptosis. In addition, 100g/L LPS and 20 μmol/L Scu were added into HK-2 cells transfected with and without CCN1 siRNA to investigate the mechanism of protective effect of Scu on LPS-induced HK-2 cells injury.

RESULTS: (1) The results of in vivo experiment: the renal function of SA-AKI mice induced by LPS was significantly decreased, and had kidney histological damage and severely damaged renal tubules. Scu could alleviate renal function and histological damage in a dose-dependent manner. Western blotting results showed Scu could reduce the protein expression of NF-κB signaling pathway related molecules and CCN1 in the renal tissue, and had a significant alleviating effect on apoptosis, indicating that CCN1 was involved in NF-κB signaling pathway activation and apoptosis. (2) The results of in vitro experiment: in HK-2 cells not treated with LPS, CCN1 overexpression had no effect on apoptosis related protein and pro-inflammatory factors of NF-κB signaling pathway. In HK-2 cells treated with LPS, overexpression of CCN1 significantly inhibited the mRNA expressions of interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) and monocyte chemoattractant protein-1 (MCP-1), with significant differences as compared with cells stimulated only by LPS [IL-1β mRNA (2-ΔΔCT): 3.20±0.57 vs. 4.88±0.69, TNF-α mRNA (2-ΔΔCT): 2.99±0.44 vs. 5.00±0.81, MCP-1 mRNA (2-ΔΔCT): 2.81±0.50 vs. 5.41±0.75, all P < 0.05], and the apoptosis-related protein was significantly down-regulated. However, when siRNA was used to inhibit the expression of CCN1, the mRNA expressions of pro-inflammatory factors were significantly increased as compared with cells stimulated only by LPS [IL-1β mRNA (2-ΔΔCT): 6.01±1.13 vs. 4.88±0.69, TNF-α mRNA (2-ΔΔCT): 5.15±0.86 vs. 5.00±0.81, all P < 0.05], and apoptosis-related protein was significantly up-regulated. In the LPS-induced HK-2 cells, the mRNA expressions of pro-inflammatory factors were significantly down-regulated after Scu treatment as compared with cells stimulated only by LPS [IL-1β mRNA(2-ΔΔCT): 2.55±0.50 vs. 6.15±1.04, TNF-α mRNA (2-ΔΔCT): 2.58±0.40 vs. 3.95±0.52, MCP-1 mRNA (2-ΔΔCT): 2.64±0.44 vs. 6.21±0.96, all P < 0.05], and apoptosis-related protein was also significantly reduced. When the expression of CCN1 was inhibited by siRNA, the protective effect of Scu on cells was weakened, which showed that the mRNA expressions of pro-inflammatory factors in cells was significantly up-regulated compared with the cells without inhibition of CCN1 expression [IL-1β mRNA (2-ΔΔCT): 5.34±0.76 vs. 2.55±0.50, TNF-α mRNA (2-ΔΔCT): 3.66±0.54 vs. 2.58±0.40, MCP-1 mRNA (2-ΔΔCT): 5.15±0.79 vs. 2.64±0.44, all P < 0.05], and the expression of apoptosis related protein was also significantly up-regulated.

CONCLUSIONS: Scu could protect the renal function in SA-AKI mice, and the protective effect is associated with NF-κB signaling pathway and CCN1. Thus, Scu could alleviate LPS-induced kidney injury by regulating the NF-κB signaling pathway.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Liu X, Qin Z, Guan C, et al. [Scutellarin alleviates lipopolysaccharide-induced renal injury via mediating cysteine-rich protein 61-connective tissue growth factor-nephroblastoma overexpressed gene 1 expression to inhibit nuclear factor-κB signaling pathway]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 35692206. doi:10.3760/cma.j.cn121430-20210401-00767

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。